U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5285430

Behavior Modification Wristwatch

A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 544/88 - 1,3-Oxazines


Subclass of Class 544 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the six-membered hetero ring has oxygen
No. of patents: 135
Last issue date: 04/22/2008


1        
NumberTitleIssue Date
7361653Pest control agent composition and method of using the same
The present invention relates to a composition for noxious organisms-controlling agent having a synergistic effect and a method for using said composition, which comprises, as active ingredients thereof, one or more compounds selected from the phthalamide derivative...
04/22/2008
7332511Vanilloid receptor ligands and their use in treatments
Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular an...
02/19/2008
7279582Retroviral protease inhibiting compounds
A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed. ...
10/09/2007
7262294Photochromatic pyrano-1,3-oxazinonaphthalene derivatives
Photochromatic compounds belonging to the groups of chromenes and spiro-pyrans having general formula (I) ...
08/28/2007
7166609Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
Pyrimidine-4,6-dicarboxylic acid diamides of the formula I are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerati...
01/23/2007
7163748Method for making solid, ungelled aminoplast crosslinkers
Methods for preparing crosslinking agents that are the ungelled reaction product of (a) at least one aminoplast resin and (b) at least one modifying compound, wherein the crosslinking agents are essentially free of active hydrogen functional groups and have a glass ...
01/16/2007
7132455Phthalamide derivatives
This invention relates to novel phthalamide derivatives of formula (I) wherein R1, R2, R3, R4, and R5 have the meanings given in the...
11/07/2006
7053138Flame-proofing agents
Compounds of formula (I) or (II), wherein R1 is C1–C18alkyl; C5–C12cycloalkyl that is unsubstituted or substituted by one or more C1–C6alkyl groups or C1–C6alk...
05/30/2006
6924251Substituted benzoylcyclohexandiones
The invention relates to novel substituted benzoylcyclohexanediones of the general formula (I), in which m, n, A, R1, R2, R3, R4 and Z are each as defined in the...
08/02/2005
6900161Azole or triazole derivatives, method for preparing same and use thereof as fungicides
The invention concerns novel azole or triazole derivatives of formula (Ia) or (Ib), wherein: X, Ar1, Ar2, Ar3, A, B and R1 are such as defined in the description, the method for preparing same and their use as fungicides. ...
05/31/2005
6780856Towards increased shelf life for cobalt(III) schiff base complexes
The invention relates to methods of stabilizing in an aqueous medium cobalt (III) Schiff base complexes and stabilized cobalt (III) Schiff base compounds therefrom. ...
08/24/2004
6777404Use of corticotropin releasing factor antagonists and related compositions
The present invention relates to compositions and methods of achieving a therapeutic effect including, the treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor...
08/17/2004
6759402Cyclic felbamate derived compounds
The present invention relates to novel felbamate derivatives and their use to treat neurological diseases such as epilepsy and to treat tissue damage resulting form ischemic events. The felbamate derivatives are modified to prevent the formation of metabolites that ...
07/06/2004
6699898Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity
The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating...
03/02/2004
6673804Sulfonamide derivatives
A compound of the formula (I) or a pharmacologically acceptable salt, ester or other derivative thereof: ##STR1## R1 is H or NHOH. R2 is H, optionally substituted alkyl, cycloalkyl or a group --AR6. A is an alkylen...
01/06/2004
6663972Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers
A crosslinking agent having reactive benzoxazine groups is provided. The crosslinking agent is an ungelled reaction product of aminoplast resin, a polyhydric aromatic compound, and at least one compound having active hydrogen groups reactive with aminopla...
12/16/2003
6642379Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
Benzamide derivatives represented by the general formula (I): ##STR1## and insecticides for agricultural and horticultural use and usage thereof, wherein Z1 is O or S; R is H, (substituted) alkyl, or alkoxycarbonyl; X is halogeno, cyano, nitro,...
11/04/2003
65766283-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
The invention relates to inhibitors of matrix metalloproteases, more specifically a 3-aryl-succinamido-hydroxamic acid of formula (I) ##STR1## and its salt, ester and derivative thereof, along with methods of producing a compound of formula (I) and pharma...
06/10/2003
65591002-benzoyl-cyclohexane-1,3-diones
Substituted 2-benzoylcyclohexane-1,3-diones of the formula I ##STR1## where: R1 and R2 are each hydrogen, mercapto, nitro, halogen, cyano, thiocyanato, C1 -C6 -alkyl, C1 -C6 -haloalkyl, C1
05/06/2003
6534492Uracil substituted phenyl sulfamoyl carboxamides
Novel uracil substituted phenyl sulfamoyl carboxamides I ##STR1## and salts thereof, where A=oxygen or sulfur; X1 =H, halogen, C1 -C4 -alkyl; X2 =H, CN, CS--NH2, halogen, C1 -C4 -alkyl, C
03/18/2003
6472529Retroviral protease inhibiting compounds
A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed....
10/29/2002
64690001,3-diheterocyclic metalloprotease inhibitors
Disclosed are compounds which are inhibitors of metalloproteases having the following structure: ##STR1## where Ar, W, X, Y, Z, R1 and R2 have the meanings described in the specification and optical isomers, diastereomers, and enanti...
10/22/2002
6451830Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for t...
09/17/2002
6448286Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors....
09/10/2002
6433124Reactive polymers and isocyanate-reactive polymers obtainable therefrom
In a compound of the formula I ##STR1## (reactive polymer), L is a, polymer, XY is a reactive radical which is inert toward NCO groups and splits off one or more protective groups Y under acidic, neutral or basic conditions and the radical X bears, after ...
08/13/2002
6417353Preparing amines
Amines are prepared by reacting aldehydes or ketones at elevated temperature under elevated pressure with nitrogen compounds selected from the group of ammonia, primary and secondary amines, and with hydrogen in the presence of a catalyst containing coppe...
07/09/2002
6358982Heterocyclyl sulphonamide derivatives
The present invention relates to the potentiation of glutamate receptor function using certain heterocyclyl sulphonamide derivatives. It also relates to novel heterocyclyl sulphonamide derivatives, to processes for their preparation and to pharmaceutical ...
03/19/2002
6358980Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
Compounds of the formula: ##STR1## useful in the treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection....
03/19/2002
6316109Aminoplast-based crosslinkers and powder coating compositions containing such crosslinkers
A crosslinking agent having reactive benzoxazine groups is provided. The crosslinking agent is the ungelled reaction product of a polyhydric aromatic compound and an aminotriazine compound having one or less non-alkylated NH bond per triazine ring. The cr...
11/13/2001
6281228Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof, or prodrug ester...
08/28/2001
6271235HIV protease inhibitors
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain the...
08/07/2001
6235901Oxazoline or oxazine acetoacetate aqueous coating compositions
A novel compound having the formula: ##STR1## wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or ...
05/22/2001
6166010Azine derivatives
The invention relates to the use of azine derivatives, some of which are known, of the formula ##STR1## in which A represents substituted phenyl, or represents in each case optionally substituted naphthyl, pyridyl, thienyl or pyrazolyl; B represents ...
12/26/2000
6150532Modulators of proteins with phosphotyrosine recognition units
The present invention relates to novel protein tyrosine phosphatase modulating compounds having the general structure shown in Formula (A1), to methods for their preparation, to compositions comprising the compounds, to their use for treatment of human an...
11/21/2000
6008223Therapeutic compounds
Compounds of formula I ##STR1## wherein Q1, Q2, Q3, and Q4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP a...
12/28/1999
5965577Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof, or prodrug ...
10/12/1999
5962437Lipid analogs for treating viral infections
A method of treating viral infections, and in particular HIV-1, hepatitis B virus and herpes viruses, is disclosed. The method comprising administering to a subject in need of such treatment an infection-combating amount of a phospholipid or phospholipid ...
10/05/1999
5936124Fluoxetine process from benzoylpropionic acid
A synthesis of fluoxetine is disclosed. The process begins with a lower alkyl ester of 3-benzoylpropionic acid, which is reduced in the presence of a chiral ligand to produce the corresponding γ-hydroxy ester, and the ester is cleaved. The free acid is t...
08/10/1999
5922748Indole derivatives as 5-HT agonists
Compounds of formula (I) ##STR1## wherein R and R1 are hydrogen, C1-4 alkyl or are linked to form a ring, A is a cycloalkyl or alkyl-cycloalkyl group, n is an integer from 0 to 3, W is an optionally substituted 5-or 6-membered hetero...
07/13/1999
5914332Retroviral protease inhibiting compounds
A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed....
06/22/1999
1        
 
Sign InRegister
Username  
Password   
forgot password?